Literature DB >> 29514180

Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?

Jotam G Pasipanodya1, Tawanda Gumbo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29514180     DOI： 10.1093/cid/ciy184

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Therapeutic Drug Monitoring: The Need for Practical Guidance.

Authors:  Jan-Willem C Alffenaar; Scott K Heysell; Stellah G Mpagama
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  Pathogen-based precision medicine for drug-resistant tuberculosis.

Authors:  Matthias I Gröschel; Timothy M Walker; Tjip S van der Werf; Christoph Lange; Stefan Niemann; Matthias Merker
Journal:  PLoS Pathog       Date:  2018-10-18       Impact factor: 6.823
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.